Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2005-12-14
pubmed:abstractText
Human epidermal growth factor receptor 2 (HER2) is overexpressed in 25-30% of ovarian carcinoma cases and a correlation between increased HER2 expression and decreased survival has been demonstrated. HER2 is a ligand-less member of the HER family that functions as the preferred coreceptor for epidermal growth factor receptor (EGFR), HER3, and HER4.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0008-543X
pubmed:author
pubmed:copyrightInfo
Copyright 2005 American Cancer Society.
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2701-8
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16265675-Animals, pubmed-meshheading:16265675-Antibodies, Monoclonal, pubmed-meshheading:16265675-Blotting, Western, pubmed-meshheading:16265675-Cell Line, Tumor, pubmed-meshheading:16265675-Cell Proliferation, pubmed-meshheading:16265675-Disease Models, Animal, pubmed-meshheading:16265675-Female, pubmed-meshheading:16265675-Growth Inhibitors, pubmed-meshheading:16265675-Humans, pubmed-meshheading:16265675-Mice, pubmed-meshheading:16265675-Ovarian Neoplasms, pubmed-meshheading:16265675-Receptor, Epidermal Growth Factor, pubmed-meshheading:16265675-Receptor, erbB-2, pubmed-meshheading:16265675-Sampling Studies, pubmed-meshheading:16265675-Sensitivity and Specificity, pubmed-meshheading:16265675-Signal Transduction, pubmed-meshheading:16265675-Transplantation, Heterologous
pubmed:year
2005
pubmed:articleTitle
2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth.
pubmed:affiliation
Division of Hematology/Oncology, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, CA 90048, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't